These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
Pubmed for Handhelds
PUBMED FOR HANDHELDS
Journal Abstract Search
97 related items for PubMed ID: 1095248
1. Investigations of allergic status and blood counts in Chinese patients receiving daily or intermittent rifampicin in Hong Kong. Clin Allergy; 1975 Jun; 5(2):189-99. PubMed ID: 1095248 [Abstract] [Full Text] [Related]
4. A controlled clinical trial of small daily doses of rifampicin in the prevention of adverse reactions to the drug in a once-weekly regimen of chemotherapy. A Hong Kong Tuberculosis Treatment Services-British Medical Research Council Investigation. Clin Allergy; 1974 Mar; 4(1):1-12. PubMed ID: 4824569 [No Abstract] [Full Text] [Related]
5. Treatment of lymph node tuberculosis--a randomized clinical trial of two 6-month regimens. Jawahar MS, Rajaram K, Sivasubramanian S, Paramasivan CN, Chandrasekar K, Kamaludeen MN, Thirithuvathas AJ, Ananthalakshmi V, Prabhakar R. Trop Med Int Health; 2005 Nov; 10(11):1090-8. PubMed ID: 16262733 [Abstract] [Full Text] [Related]
6. Adverse reactions to daily and intermittent rifampicin regimens for pulmonary tuberculosis in Hong Kong. Aquinas M, Allan WG, Horsfall PA, Jenkins PK, Hung-Yan W, Girling D, Tall R, Fox W. Br Med J; 1972 Mar 25; 1(5803):765-71. PubMed ID: 4259217 [Abstract] [Full Text] [Related]
9. A controlled trial of 6 months' chemotherapy in pulmonary tuberculosis. Final report: results during the 36 months after the end of chemotherapy and beyond. British Thoracic Society. Br J Dis Chest; 1984 Oct 25; 78(4):330-6. PubMed ID: 6386028 [Abstract] [Full Text] [Related]
11. [Short-term therapy of lung tuberculosis using a fixed combination of isoniazid, rifampicin and pyrazinamide. Results after 2 years]. Brändli O, Haegi V, Villiger B, Bohn W, Baumann HR, Zäch R. Schweiz Med Wochenschr; 1989 Mar 11; 119(10):299-305. PubMed ID: 2652281 [Abstract] [Full Text] [Related]
13. Induction of rifampicin metabolism during treatment of tuberculous patients with daily and fully intermittent regimens containing the drug. Immanuel C, Jayasankar K, Narayana AS, Santha T, Sundaram V, Sarma GR. Indian J Chest Dis Allied Sci; 1989 Mar 11; 31(4):251-7. PubMed ID: 2576931 [Abstract] [Full Text] [Related]
15. [Combination of ethambutol with ethionamide, cycloserine and-or pyrazynamide in retreatment of pulmonary tuberculosis]. Kekkaku; 1968 Feb 11; 43(2):91-5. PubMed ID: 5678013 [No Abstract] [Full Text] [Related]
16. A comparative study of daily followed by twice or once weekly regimens of ethambutol and rifampicin in retreatment of patients with pulmonary tuberculosis. The results at 1 year. A cooperative tuberculosis chemotherapy study in Poland. Tubercle; 1975 Mar 11; 56(1):1-26. PubMed ID: 1096388 [Abstract] [Full Text] [Related]
18. [Controlled comparison of daily and intermittent treatment regimens with rifampicin]. Yamamoto K. Bull Int Union Tuberc; 1974 Mar 11; 49(1):442-6. PubMed ID: 4619565 [No Abstract] [Full Text] [Related]
19. Controlled trial of four thrice-weekly regimens and a daily regimen all given for 6 months for pulmonary tuberculosis. Lancet; 1981 Jan 24; 1(8213):171-4. PubMed ID: 6109855 [Abstract] [Full Text] [Related]